T0	Outcomes 638 678	the frequency of serious adverse events.
T1	Outcomes 679 741	Peripheral blood counts, CD34(+) count, and functional outcome
T2	Outcomes 761 840	assessed lesion volume, atrophy, and the presence of iron-labeled CD34(+) cells
T3	Outcomes 900 917	at mean of 8 days
T4	Outcomes 1146 1180	with serious adverse events: G-CSF
T5	Outcomes 1224 1247	20, death or dependency
T6	Outcomes 1320 1357	or the number of injections received.
T7	Outcomes 1358 1409	G-CSF increased CD34(+) and total white cell counts
T8	Outcomes 1471 1510	reduction in MRI ischemic lesion volume
T9	Outcomes 1628 1649	labeled CD34(+) cells